Shree Pacetronix Quarterly Results for Trading Insights
In Sept 2025, Shree Pacetronix (SHREEPAC) reported revenue ₹7 Cr and net profit ₹1 Cr — revenue +75.0% YoY. Compare with SHREEPAC fair value estimate to assess whether the stock is under or overvalued.
SHREEPAC Quarterly Results — Revenue, Profit & EPS Highlights
Shree Pacetronix latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore SHREEPAC share price data to track price trends across different timeframes.
- Revenue of ₹7 Cr in Sept 2025 (+75.0% vs Mar 2025, +75.0% vs Sept 2024)
- Net Profit of ₹1 Cr in Sept 2025
- EBITDA of ₹2 Cr in Sept 2025 (+100.0% vs Mar 2025)
- Operating Margin of 31.0% in Sept 2025 (+8.0pp vs Mar 2025)
- Earnings Per Share of ₹3.64 in Sept 2025 (+188.9% vs Mar 2025)
Shree Pacetronix Quarterly Results — Revenue, EBITDA, Net Profit & EPS
SHREEPAC quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 7 | 4 | 5 | 4 | 4 | 75.0% | 75.0% |
| Net Profit (₹ Cr) | 1 | 0 | 1 | 0 | 0 | - | - |
| EBITDA (₹ Cr) | 2 | 1 | 1 | 0 | 0 | - | - |
| EPS (₹) | 3.64 | 1.26 | 1.85 | 0.16 | 0.09 | - | - |
| Operating Margin (%) | 31.0% | 23.0% | 22.0% | 10.0% | 10.0% | - | - |
SHREEPAC Share Price Trend — 1-Year Movement Across Quarterly Results
Shree Pacetronix 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit SHREEPAC share price screener.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
SHREEPAC vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap
Shree Pacetronix latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹450,643.09 Cr | 1880.3 | 14,875 | 3,125 | +10.8% | - | 21.0% | 144.6 |
|
Divis Laboratories
Sept 2025 |
₹179,470.03 Cr | 6893.0 | 2,860 | 689 | +7.1% | - | 24.1% | 265.4 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹148,702.77 Cr | 4429.2 | 3,219 | 591 | +11.3% | - | 18.4% | 252.5 |
|
Cipla
Mar 2026 |
₹115,205.68 Cr | 1399.5 | 6,612 | 543 | -14.3% | -4.0% | 8.2% | 203.7 |
|
Dr Reddys Laborator…
Mar 2026 |
₹111,107.68 Cr | 1321.9 | 7,996 | 221 | -12.5% | -11.5% | 2.8% | 498.8 |
All amounts in ₹ Crores